Neonatal thymectomy (NTx), especially around day 3 after birth, causes various organ-specific autoimmune diseases in mice. This report shows that: (a) T cells expressing the interleukin 2 receptor cx chains (CD25) ontogenically begin to appear in the normal periphery immediately after day 3, rapidly increasing within 2 wk to nearly adult levels (~10% of CD3 + cells, especially ofCD4 + cells); (b) NTx on day 3 eliminates CD25 + T cells from the periphery for several days; inoculation immediately after NTx of CD25 + splenic T cells from syngeneic non-Tx adult mice prevents autoimmune development, whereas inoculation of CD25-T cells even at a larger dose does not; and furthermore, (c) similar autoimmune diseases can be produced in adult athymic nu/nu mice by inoculating either spleen cell suspensions from 3-d-old euthymic nu/+ mice or CD25 + cell-depleted spleen cell suspensions from older, even 1-yr-old, nu/+ mice. The CD25-populations from neonates or adults are also similar in the profile of cytokine formation. These results, taken together, indicate that one aspect of peripheral self-tolerance is maintained by CD25 + T ceils that sustain potentially pathogenic self-reactive T ceils in a CD25-dormant state; the thymic production of the former is developmentally programmed to begin on day 3 after birth in mice. Thus, NTx on day 3 can, at least transiently, eliminate/ reduce the autoimnmne-preventive CD25 + T cells, thereby leading to activation of the selfreactive T ceils that have been produced before NTx.
A lthough the etiology of spontaneous autoimmune diseases is largely unknown at present, autoimmune disease may develop as a consequence of altered control of potentially pathogenic self-reactive lymphocytes that recognize antigenically normal self-constituents (1) . Indeed, simple manipulation of the thymus/T cells, without exogenous immunization with self-antigens in potent adjuvant, can cause autoimmune disease in normal animals (for reviews see references 2 and 3). For example, neonatal thymectomy (NTx)l, especially between days 2 and 4 after birth, of selected strains of normal mice, produces various autoimmune diseases, such as hemolytic anemia, thyroiditis, gastritis, oophoritis, or orchitis (4) (5) (6) (7) (8) (9) (10) (11) . In this report, V Abbreviations used in this paper: as, antisense; NTx, neonatal thymectomy; RT, reverse transcriptase, s, sense; Tx, thymectomy.
The results of this work were reported at the annual meeting of the Japanese Society of Immunology in November 1993 and at the 9th International Congress of Immunology in July 1995. we investigate the mechanism by which NTx causes autoimmune disease in normal mice, and thereby attempt to show how the normal immune system developmentally controls potentially pathogenic self-reactive T cells.
Based on various T cell abnormalities in NTx mice, several possible mechanisms have been proposed on the NTxinduced autoimmune disease, such as: insufficient clonal deletion in neonatal period and the inability of NTx mice to eliminate leaked self-reactive T cell clones that would be deleted in normal non-Tx mice upon recirculation through the thymus (12) (13) (14) (15) ; reduction/elimination of an immunoregulatory T cell population by NTx (16) ; NTx-induced alteration of lymphocyte population kinetics towards expansion of self-reactive T cells (17, 18) ; or infection with autoimmune-eliciting viruses due to NTx-induced immunodeficiency (19) . It remains obscure, however, which of these plausible mechanisms is the primary one by which NTx triggers autoimmune disease. To determine a particular NTx-induced T cell abnormality as the primary triggering event of the autoimmune development, correction of the abnormality must prevent autoimmune disease in NTx mice, and, further, the same autoimmune disease must be produced by introducing the abnormality itself into normal mice direcdy, not indirectly by NTx.
We and others (20) (21) (22) (23) have previously shown that autoimmune diseases, including those produced by NTx, spontaneously developed dn normal rodents when CD5 high or CD45RB/C l~ cells v~ere eliminated from the peripheral CD4 + population; rer of the respective eliminated population prevented autoimmune development. Assuming that CD4 + T ce~ capable of preventing NTxautoimmune disease may well be CD5hig h and CD45RB l~ and begin to appear in the periphery around day 3 after birth in normal ontogeny, w.e have searched for a T cell surface molecule that is more specific than CD5 or CD45RB/C in delineating such an autoimmune-preventive CD4 § population. This search revealed the IL-2 receptor c~ chain (CD25) molecule as a candidate, since CD25 is expressed on a subpopulation ofCD5 hi~ and CD45RB l~ CD4 + cells (24) . In this report, we show that CD25-expressing T cells ontogenically begin to appear in the periphery immediately after day 3, and NTx-induced autoimmune disease can be prevented by inoculating CD25 + splenic T cells from nonTx normal mice; furthermore, similar autoimmune diseases can be produced in adult mice by directly eliminating peripheral CD25 + T cells. Our.results indicate that self-tolerance is developmentally established not only by clonal deletion but also by T cell-mediated control of self-reactive T cells.
Materials and Methods
Mice. BALB/c mice, BALB/c nu/nu mice of 6 wk of age, and BALB/c nu/+ mice of 8 wk of age were purchased from Japan SLC, Inc. (Shizuoka, Japan). They were maintained in the animal facility of the Institute of Physical and Chemical kesearch (R.IKEN). To obtain newborn BALB/c mice, mice were mated in our facility.
NTx. Tx was performed on day 3 after birth (the day of birth as day 0). Mice were anesthesized by keeping them in crushed ice for 2-3 min, and the thymus was removed en bloc under a dissecting microscope with a cottonhead toothpick (25) . Sham Tx was performed by cutting the sternum without removal of the thymus. The wound was sutured and the mice were kept at 30~ overnight and then returned to their mothers.
Preparation of T Cell Subpopulations. Lymphocyte suspensions (5 • 107) prepared from spleens and lymph nodes (inguinal, axillary, brachial, and mesenteric) were incubated in 12 • 75-mm glass tubes (Coming, Coming, NY) with 100 ~1 of 1 : 10-diluted ascites of anti-CD25 (7D4, rat IgM) (26) , anti-L3T4 (CD4) (GK1.5, rat IgG2b) (27) , or anti-Lyt-2.2 (CD8) (mouse IgG2a) (28) for 45 rain on ice. They were washed once with HBSS (GIBCO BRL, Gaithersburg, MD) and incubated with 1.0 ml of nontoxic rabbit serum (GIBCO BR.L) 1 : 5-diluted with Medium 199 (GIBCO BR.L) for 30 rain in a 37~ water bath with occasional vigorous shakings; 100 Ixg of DNase I (Sigma Chemical Co., St. Louis, MO) was added for the last 5 min of the incubation. The suspensions were then washed twice with HBSS, and injected intraperitoneally into NTx mice 1 wk after NTx or intravenously into 6-8-wk-old female nu/nu mice (24) . To remove CD4 § cells completely after anti-L3T4 + C treatment, the treated cells were incubated for 1 h at 4~ on plastic dishes precoated overnight with affinity-purified anti-rat IgG (Cappel-Organon Teknika, West Chester, PA), and nonadherent cells were collected (24) . Less than 1% oflymphocytes after the anti-Lyt-2.2 + C, anti-L3T4 + C and subsequent panning treatment, or anti-CD25 (7D4) and anti-Lyt-2.2 + C treatment, were positive for FITC-rat anti-Lyt-2 (CDS) (53-6.7) (29), FITC-F(ab')2 anti-rat IgG (Jackson ImmunoR.esearch, West Grove, PA), or anti-CD25 (PC61) (30) plus FITC-anti-rat IgG staining, respectively.
For enrichment ofCD25 + T cells, spleen and lymph node cell suspensions were first enriched for CD4 § cells by incubating the cells with the mixture of culture supematants ofJllD (rat IgM) (31) and anti-CD8 (rat IgG) (29) , and then panned on plastic dishes precoated overnight with affinity-purified anti-rat IgG (Cappel-Organon Teknika). The CD4 § cells (>90% pure) were then panned on plastic dishes precoated overnight with purified 7D4 mAb (100 t.tg/ml), and the adherent cells were collected by scraping with a rubber policeman. They were 50--60% pure for CD25 + cells. To obtain a pure CD4 + CD25 + or CD4 + CD25-population for reverse transcriptase (RT)-PCR analysis (see below), cells stained with PE-anti-CD4 and FITC-anti-CD25 were sorted by a FACStar | flow cytometer with Consort 30 program (Becton Dickinson & Co., Mountain View, CA) as previously described (32) .
Flow Cytometric Analysis. 106 cells were stained with FITCanti-CD3 (145-2Cll) (33) and biotinylated anti-CD25 (7D4), purchased from PharMingen (San Diego, CA), and PE-streptavidin (Biomeda, Foster City, CA) as the secondary reagent, and then analyzed by a FACScan | flow cytometer (Becton Dickinson & Co.), as previously described (24) .
ELISA for Detecting Serum Autoantibodies. A detailed description of the ELISA (using alkaline phosphatase--conjugated secondary antibody and p-nitrophenyl disodium hexahydrate as the substrate) used to detect autoantibodies against gastric parietal cells was given earlier (34) .
Histology and Criteria for Grading Autoimmune Disease. Tissues and organs (thyroid, lung, pancreas, stomach, adrenal gland, kidney, ovaries, or testes) were fixed in 10% formalin and processed for hematoxylin and eosin staining. Gastritis was graded from 0 to 2+ depending on macroscopic and histological severity: 0 = the gastric mucosa was histologically intact; 1 + = gastritis with histologically evident destruction of parietal cells and cellular infiltration of the gastric mucosa; and 2+ = severe destruction of the gastric mucosa accompanying the formation of giant rugae due to compensatory hyperplasia of mucous-secreting cells (see reference 20 for the giant rugae) (24) .
RT-PCR. Total cellular ILNA was isolated from l0 s FACS | sorted cells by modification of the guanidium isothiocyanate method (35) . RNA was converted to eDNA with oligo-dT primer and Moloney murine leukemia virus R.T (Toyobo, Osaka, Japan). The eDNA was preamplified with random 15-nucleotide primers; each aliquoted eDNA sample was then amplified with specific primers (see below) in Falcon Microtest III flexible U-bottomed, 96-well assay plates (Becton Dickinson Labware, Oxnard, CA) on a PTC-100 programmable thermal controller (MJ Research Inc., Watertown, MA). PClk conditions were strictly defined for each primer pair. The following sequences (sense [s] and antisense [as]) were synthesized and used as the primers:
(as) 5'-GTTCCACATGTTGCTCCACACTTG-3'; and TNF-el (s) 5'-CCACGTCGTAGCAAACCACC-3', (as) 5'-AAGTAC-TTGGGCAGATTGACCTC-3'. The RT-PCR products were electrophoresed on 1.5% agarose (FMC BioProducts, Rockland, ME) gels and stained with ethidmm brmmde.
Results
blduction qf Autoimmune Disease by NTx. Tx on day 3 after birth produced, in 3 too, histologically evident gastritis accompanying high titers of circulating antiparietal cell autoantibodies in "-40% of BALB/c mice, and oophoritis with annoocyte autoannbodies m 20% of mice. Tx on day 0 or 7 was far less efiqcient for autounmune induction (15% incidence of gastritis and no oophoritis), and Tx on day 14 or adult (6 wk of age) was unable to elicit autolmmumty ( The time course study of serological and histological development of gastric autoimmunity after day 3 Tx showed that significant titers of antiparietal cell autoantibo&es became detectable by ELISA from 3 to 4 wk after Tx (Fig. 1 B) . It took 5--6 wk for inflammatory destruction of the parietal cells to become histologically evident, although cellular infiltration to the gastric mucosa began earlier (data not shown). The degree of histological severity of the gastritis was well correlated with the titers of antiparietal cell autoanttbo&es when Tx mice were examined at 2 mo of age. These results indicate that pathogenic self reactive T cells are activated within a couple of weeks after day 3 Tx.
Omoge~l F of CD25 + T Cells and Effects of NTx on the Ontogen),.
By flow cytometric analysis, few splenic CD3* cells expressed CD25 in 3-d-old mice (0.06 + 0. l%, n = 7); in contrast, a significant fraction of CD3 + cells expressed CD25 m 7-d-old (5.48 4-0.93%, n = 5) or adult mice (10.8 _+ 1.01%, n = 1 l) (Fig. 2 A) . In infant as well as adult mice, 5-10% ofCD4 + cells and <l% ofCD8 § spleen cells expressed CD25; the majonty ofCD25 + cells dM not coexpress IL-2RI3 (24) . We noted that a larger fraction of B cells of neonatal mice expressed CD25, compared with adult mice (Fig. 2 A) . These B cells may be immature B cells as demonstrated for a smMar immature population in the adult bone marrow (36 Similar analyses of CD25-expressing T cells in normal BALB/c mice at various ages revealed that CD3 + CD25 + cells began to appear m the spleen immediately after day 3, rapidly increasing within 2 wk to adult levels in percentage among CD3 + cells (Fig. 2 B) and in absolute numbers (Fig.  2 C) . Other mouse strains, such as A/J and C57BL/6 (which are high-and low-incidence strain, respecnvely, of NTxreduced autoimmune disease [91), also showed ontogemc patterns of CD25 + T cells sinular to BALB/c (data not shown). Tx on day 3 not only reduced the number ofCD3 + cells, especially CD4 + cells, but also depleted CD3 + CD25 + cells for 1 wk after Tx (Fig. 2 C) . 3 mo after NTx, CD25 ~ T cells constituted 19.6 ---2.6% (n = 5) of splenic CD4 + cells and 4.4 + 2.6% (n = 5) ofCD8 § cells, indicating that they might have developed from the CD25-T cell population that had migrated to the periphery before NTx (see also development in NTx mice, graded numbers of splenic T cell subpopulations from syngeneic non-Tx adult mice were inoculated into NTx mice 1 wk after NTx; the recipients were histologically and serologically examined 3 mo later (Fig. 3) . CD4 + CD25-cell suspensions, adjusted to an autoimmune-preventive dose of CD4 + cells (107), failed to prevent gastritis. On the other hand, a small dose (2 • 10 ~) of cell suspensions enriched for CD4 + CD25 + cells prevented autoimnmnity, but an equivalent dose of CD4 + cells did not. CD8 + cells, ~'-,1% of which expressed CD25 (24), were far less effective for prevention when compared with an equivalent dose of CD4 + cells (10v). We obtained similar results of CD25 + cell-mediated autoinmmne prevention on other NTx-induced autoimmune diseases in other strains, e.g., autoimmune oophoritis in A/J mice (15) (Sakaguchi, S., unpublished data). Taken together, these results indicated that the autoimmune-preventive activity was mainly, if not solely, in the CD25 + CD4 + population.
To determine the fate and CD25-phenotypic change of the inoculated CD4 subpopulations (CD4 +, CD4 + CD25 , or CD4 § CD25 + cells), they were prepared from the spleens of BALB/c Thy-1" mice and inoculated into day 3 Tx BALB/c mice, which are Thy-I I' (Fig. 4) were present 2 mo after inoculation in the NTx mice inoculated with Thy-l.1 + CD4 + CD25 + cell-enriched suspensions (50-60% pure for CD25 + cells) compared with those inoculated with whole CD4 + or CD4 + CD25-cells (in these mice, CD25 + cells constituted "o10% of Thy-l.1 + cells). Thus, at least some of the inoculated CD25 + T cells persisted and presumably proliferated as CD25 +. Furthermore, appearance ofCD25 + Thy-l.1 + cells in NTx mice inoculated with CD25-Thy-l.1 + cells indicated that a fraction of inoculated CD25-cells had differentiated to CD25 + cells, as was also suggested by the finding that NTx mice developed CD25 + T cells (Fig. 2 C) . well. This indicates that the condition of T cells in 3-d-old mice may be critical for autoimmune induction, whereas age-dependent differences, if any, in the conditions of the target antigens (37) , the functions of antigen-presenting or B cells (38, 39) , or other host conditions, may not.
Induction of Autoimmune Disease in nu/nu Mice by Transfer of Newborn Spleen Cells or CD25 + Cell-depleted Spleen Cells from Older Mice at
Furthermore, comparable incidences of autoimmune diseases developed in nu/nu mice whether the transferred CD25-cells were prepared from 2 or 12-mo-old nu/+ mice. Thus, the potentially pathogenic self-reactive T cells were present in the periphery of aged as well as neonatal or young mice; they were not significantly deleted (12) (13) (14) (15) 40) , rendered anergic (14), or diluted out in the periphery with aging (13) . Moreover, elimination/reduction ofCD25 + T cells could activate the self-reactive T ceils at any age. of cytofluorometric study that few CD4 + cells of 3-d-old mice express CD25 (Fig. 2 A) . CD4 § cells from 3-, 7-, or 60-d-old mice, as well as CD4 + CD25 + or CD4 + CD25 cells from 60-d-old mice, transcribed a comparable level of IL-2, IFN-'y, or TNF-o~ gene. In contrast, IL-4, IL-10, or TGF-[3 transcripts were predominantly detected in CD4 + cells from 7-d-old or adult mice, especially in CD25 + CD4 + cells, compared with CD4 + cells from 3-d-old mice or CD25-CD4 + cells from adults. Thus, the CD4 + cells of 3-d-old mice were similar to CD25-CD4 + cells of adult mice not only in the nonexpression of CD25 molecules but also in their cytokine profile; the CD25 + CD4 + population, which began to appear in the periphery immediately after day 3, predominantly contained cells forming IL-4, IL-10, and/or TGF-13.
Transcription of Cytokine Genes in Splenic CD4 + Cells from

Discussion
The main conclusion from the data in this report is that one aspect of peripheral self-tolerance is maintained by CD25 + T cells that sustain potentially pathogenic self-reactive T cells in a CD25-dormant state. The ontogenic time course of the former is intrinsically programmed as the developmental process in normal mice and abnormality in this process can cause autoimmune disease in genetically susceptible individuals.
We showed that CD25 + T cells ontogenically began to appear in the periphery of normal mice from day 3 after birth. Hence, Tx on day 3 transiently depleted/reduced CD25 + T cells from the periphery, inoculation of CD25 + T cells from non-Tx mice effectively prevented autoimmune development, and transfer of CD25-T cells from 3-d-old or older nu/+ mice successfully induced similar autoimmune disease in nu/nu mice. These results, taken together, indicate the following: (a) the thymus of an apparently nonautoimmune strain of mice (such as BALB/c) produces not only potentially pathogenic self-reactive T cells (which persist in the normal periphery at a CD25-dormant state) but also CD25 + T cells capable ofdownregulating the activation/expansion of self-reactive T cells O n e may argue, however, that a quantitative change of T cell n u m b e r in ontogeny, not a qualitative change of T cell subpopulations, may be responsible for autoimmune development after NTx. For example, a T-lymphocytopenia due to N T x might incur viral infection and the resultant activation of antigen-presenting cells might lead to activation of self-reactive T cells (19) . This does not seem to be the case for the following reasons. First, a deliberate preparation of T-lymphocytopenia in nu/nu mice by inoculating a small number (e.g., 2 • 106) o f n u / + spleen cells failed to produce autoimmune disease, whereas a large n u m b e r of C D 2 5 -nu/+ T cells (e.g., prepared from 3 • 107 spleen cells) effectively produced autoimmune disease. Second, transplantation of nu/+ newborn thymuses in nu/nu mice produced similar autoimmune diseases without T-lymphocytopenia (41) . Third, others have shown that maintenance of germ-free NTx mice in germ-flee conditions could not prevent autoimmune development (42) .
The autoimmune-preventive CD25 + CD4 + cells in norreal unimmunized mice were apparently indistinguishable from "activated," "memory," or "effector" T cells not only in their expression patterns of various cell surface molecules (including CD45RB and CD5 [24] ) but also cytokine formation (Fig. 5) (43-45) . Indeed, the CD25-T cell population gave rise to CD25 + activated, effector T cells (24, and Fig. 4) . Furthermore, polyclonal CD25 + activated T cell blasts prepared by mitogen stimulation of normal T cells effectively prevented NTx-induced autoimmune disease (Sakaguchi, S., unpublished data). Although it remains to be determined whether any T cells acquire the autoimmune-preventive activity upon activation, these findings suggest that the ontogenic time course and the basal number of the autoimmune-preventive CD25 + population may be developmentally programmed, but the size of the population may not be innately fixed and may increase when T cells are activated in immune responses to non-self antigens (24) . To elucidate further the mechanism of this CD25 + T cell-mediated control, it is currently under investigation whether cytokines, such as IL-4, IL-10, or TGF-[3, predominantly produced by CD25 + CD4 + T cells (Fig. 5 ), are responsible for sustaining self-reactive T cells in the CD25-dormant state.
The CD25 + T cell-mediated immunoregulation is the key, but not the sole, mechanism of controlling pathogenic self-reactive T cells. Indeed, others have shown that intrathymic expression of the gastric parietal cell antigens inhibited NTx-induced gastritis (46, 47) . Given the fact that T cells bearing high affinity TCRs for intrathymic selfantigens or peripheral organ~specific antigens circulating to the thymus can be clonally deleted (even at a much lower antigen concentration than that required for activation [48] ), it is likely that potentially pathogenic self-reactive T cells that have escaped the thymic-negative selection, may bear low affinity TCRs for the relevant self-antigens, hence high thresholds for activation. The CD25 + T cellderived suppressive signal may further raise the thresholds, thereby stably maintaining them in the CD25-dormant state even when they recognize self-peptides presented by antigen-presenting cells (49) . By contrast, some, if not all, T cells specific for non-self antigens may easily overwhelm the suppression and become activated upon antigen stinmlation presumably because of their high affinity TCtLs for the antigens, and hence, low activation thresholds, even though the CD25 + T cell-derived suppressive signal may raise the thresholds to the same extent as for self-reactive T cells. The T cell-mediated peripheral immunoregulation and the thymic clonal deletion may thus cooperatively sustain stable self-tolerance while enabling effective imnmne responses to non-self antigens.
The present findings in mice may also apply to other species and other autoimmune diseases. For example, NTx causes or aggravates thyroiditis in chickens (50) and rats (51) . Furthermore, spontaneous autoimmune diseases (e.g., diabetes mellitus and thyroiditis in NOD mice or BB rats) can be prevented by inoculating CD4 + cells from the histocompatible nomlal animals before clinical onset of autoimmune disease (52, 53) . The autoimmune-preventive CD4 + T ceils in these models might be CD25 +, and the models might have genetically determined abnormality in the CD25 + cell-mediated control of self-reactive T cells. Further molecular analysis of the autoimmune-preventive activity of CD25 + T cells and search for environmental agents or genetical abnormalities reducing CD25 + T cells, retarding their ontogeny, or affecting their autoimmunepreventive activity, would contribute to our understanding of the etiology and pathogenetic mechanism of autoimmune disease.
